Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2025-12-31 @ 10:42 AM
Study NCT ID:
NCT00503906
Status:
COMPLETED
Last Update Posted:
2017-05-12
First Post:
2007-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer
Sponsor:
University of Miami
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-17
First Submit QC Date:
None
Study First Post Date:
2007-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-01-22
Results First Submit QC Date:
None
Results First Post Date:
2013-04-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-10
Last Update Post Date:
2017-05-12
Last Update Post Date Type:
ACTUAL